Nutrition
Showing 9976 - 10000 of >10,000
HIV, Communication Research Trial in Denver, La Romana (Info Viz for Health)
Active, not recruiting
- HIV
- Communication Research
- Info Viz for Health
-
Denver, Colorado
- +1 more
Jun 22, 2022
Sepsis Trial (Omega 3, Placebo)
Completed
- Sepsis
- Omega 3
- Placebo
- (no location specified)
Dec 24, 2017
Chronic Lymphocytic Leukemia, CLL Trial in La Jolla (Revlimid, Rituximab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- CLL
-
La Jolla, CaliforniaUniversity of California, San Diego
Sep 2, 2021
Breast Cancer, Cancer of Breast, Breast Carcinoma Trial in Phoenix, Saint Louis, Buffalo (drug, biological, procedure, genetic)
Application of n-3 Fatty to Patient of Jaundice
Completed
- Obstructive Jaundice
- Surgical Procedure, Unspecified
- trail cohort
- control cohort
-
Wuhan, Hubei, ChinaHepatic Surgery Center of Tongji Hospital
Dec 13, 2017
Salt; Excess, Hypertension Trial in Porto (SALT CONTROL H equipment to control and monitor salt during cooking process)
Active, not recruiting
- Salt; Excess
- Hypertension
- SALT CONTROL H equipment to control and monitor salt during cooking process
-
Porto, PortugalCarla Gonçalves
Jan 7, 2021
Leukemia Trial in Houston (MEK 162)
Terminated
- Leukemia
- MEK 162
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2021
Hiv, HIV, HIV Lipodystrophy Trial in Denmark (Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO],
Recruiting
- Hiv
- +6 more
- Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]
- Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
-
Aalborg, Denmark
- +4 more
May 21, 2021
Adenovirus Trial in Worldwide (Standard of Care, Brincidofovir)
Graft Rejection Trial in Germany, United States (Placebo, C1 Esterase Inhibitor (Human))
Completed
- Graft Rejection
- Placebo
- C1 Esterase Inhibitor (Human)
-
Los Angeles, California
- +4 more
Jun 2, 2021
Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)
Completed
- Breast Cancer
- Cancer
- Nivolumab
- +2 more
-
Whittier, California
- +35 more
Jul 14, 2022
COVID-19 Pneumonia Trial in Worldwide (Placebo, Tocilizumab)
Active, not recruiting
- COVID-19 Pneumonia
- Placebo
- Tocilizumab
-
Phoenix, Arizona
- +50 more
Sep 23, 2021
Type 1 Diabetes Trial in Puerto Rico, United States (HOE901-U300 (Insulin Glargine 300 U/ml), Lantus (Insulin Glargine 100
Completed
- Type 1 Diabetes Mellitus
- HOE901-U300 (Insulin Glargine 300 U/ml)
- +2 more
-
Little Rock, Arkansas
- +99 more
Mar 21, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)
Hypertension, Dietary Modification, Health Behavior Trial (Behavioral Intervention Group)
Not yet recruiting
- Hypertension
- +2 more
- Behavioral Intervention Group
- (no location specified)
May 23, 2021
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in United
Completed
- Acute Biphenotypic Leukemia
- +4 more
- Cyclophosphamide
- +7 more
-
Duarte, California
- +7 more
Jun 13, 2021
Obesity Trial in Toulouse (dietary restrictions)
Completed
- Obesity
- dietary restrictions
-
Toulouse, FranceUniversity Hospital Toulouse
Jan 3, 2018
Anxiety, Pain, Health Knowledge, Attitudes, Practice Trial in Chicago (Companion Present)
Completed
- Anxiety
- +2 more
- Companion Present
-
Chicago, IllinoisPrentice Women's Hospital
Nov 11, 2021
NSCLC With EGFR-Activating Mutations Trial in Worldwide (Dacomitinib (PF-00299804), Gefitinib)
Completed
- Non-small Cell Lung Cancer With EGFR-Activating Mutations
- Dacomitinib (PF-00299804)
- Gefitinib
-
Beijing, China
- +51 more
Feb 10, 2022
Heart Failure, Healthy Volunteer Trial in Worldwide (AMG 986 IV, AMG 986 PO, Placebo PO)
Terminated
- Heart Failure
- Healthy Volunteer
- AMG 986 IV
- +3 more
-
Anaheim, California
- +24 more
Mar 30, 2022
COVID-19 Trial in Vienna (Exercise)
Completed
- COVID-19
- Exercise
-
Vienna, AustriaMedical University of Vienna
Dec 23, 2021